Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation).[1][2][3][4][5] It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection.[3][4][5] The medication is available in Argentina and Paraguay.[1][2][3]
 | |
 | |
| Combination of | |
|---|---|
| Estradiol hemisuccinate | Estrogen |
| Progesterone | Progestogen |
| Clinical data | |
| Trade names | Hosterona |
| Other names | EHS/P4 |
| Routes of administration | Intramuscular injection |
See also
editReferences
edit- ^ a b "Hosterona". Drugs.com. Retrieved 2019-04-12.
- ^ a b Sweetman SC, ed. (2009). "Sex hormones and their modulators". Martindale: The Complete Drug Reference (36th ed.). London: Pharmaceutical Press. pp. 2101, 2127. ISBN 978-0-85369-840-1.
Estrone [...] Progesterone [...] Multi-ingredient: [...] Arg.: [...] Hosterona
- ^ a b c "What is HOSTERONA and what is it for?" [Qué es HOSTERONA y para qué sirve?]. MatchMyRx (in Spanish).
- ^ a b "Hosterona". Los Medicamentos. 23 November 2012.
- ^ a b "Hosterona". Vademecum Paraguay.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |